Workers Value Employer-Sponsored Health Coverage

Translate to Spanish or other 102 languages!

Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers. Image for illustration purposes
Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers. Image for illustration purposes

Mega Doctor News

- Advertisement -

‌US CHAMBER OF COMMERCE

Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers.

Why it matters: The findings from a survey sponsored by Protecting Americans Coverage Together – a coalition that includes the Chamber – reaffirm the high degree of importance workers have in employer-sponsored health insurance (ESI). Policymakers should do more to support and strengthen it.

- Advertisement -

By the numbers:

·  96% said health insurance was either “Extremely important” (83%) or “Very important” (13%) to them

·  93% said they were satisfied with their insurance

·  87% said their plans are affordabl

- Advertisement -


Be smart: 89% of Americans prefer to get health coverage through an employer than through other means.

·  And: 81% said they would rather receive their coverage from an employer than a government-provided health plan

Our take: “Employees value their employer-sponsored health coverage,” said Katie Mahoney, Chamber Vice President of Health Policy. “ESI is working for the people with access to it, and the goal of policymakers should be to strengthen and bolster the system to help more people.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -